Aspiriant LLC’s iShares MSCI Switzerland ETF EWL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$269K Sell
4,580
-323
-7% -$19.8K 0.01% 296
2025
Q4
$294K Buy
+4,903
New +$282K 0.01% 283
2016
Q3
Sell
-12,010
Closed -$393K 193
2016
Q2
$393K Buy
+12,010
New +$363K 0.04% 148

Other funds holding EWL

Aspiriant LLC's EWL Position: Q1 2026 in Review

Aspiriant LLC reduced its iShares MSCI Switzerland ETF (EWL) stake by 6.6% in Q1 2026, selling an estimated $19.8K and leaving 4,580 shares worth $269K. The position accounts for 0.01% of the portfolio, ranked #296.

Aspiriant LLC first reported a position in EWL in Q2 2016 and has held it in 3 quarters since. The position peaked at $393K in Q2 2016. 186 funds tracked by Wall St. Rank hold EWL as of Q1 2026.

  • Aspiriant LLC held 4,580 shares of iShares MSCI Switzerland ETF worth $269K as of Q1 2026.
  • Aspiriant LLC sold 323 iShares MSCI Switzerland ETF shares in Q1 2026, an estimated $19.8K.
  • iShares MSCI Switzerland ETF made up 0.01% of Aspiriant LLC's portfolio in Q1 2026, its #296 holding.
  • Aspiriant LLC first reported a position in iShares MSCI Switzerland ETF in Q2 2016 and has held it in 3 quarters since.
  • Aspiriant LLC's iShares MSCI Switzerland ETF position peaked at $393K in Q2 2016.
  • 186 funds tracked by Wall St. Rank held iShares MSCI Switzerland ETF as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.